Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma

Breast Cancer Research and Treatment

Volumn 54, Issue 1, 1999, Pages 59-64

  Griffith, Jeffrey K ^a   Bryant, Jennifer E ^a   Fordyce, Colleen A ^a   Gilliland, Frank D ^a,b   Joste, Nancy E ^a   Moyzis, Robert K ^c,d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aneuploidy; Breast cancer; Genomic instability; Metastasis; Prognostic markers; Telomeres

Indexed keywords

PARAFFIN;

AGE; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA CONTENT; FEMALE; FROZEN SECTION; GENETIC STABILITY; GENOME; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TELOMERE; TREATMENT OUTCOME; TUMOR VOLUME;

ANEUPLOIDY; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; DNA, NEOPLASM; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TELOMERE;

EID: 0032930152     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006128228761     Document Type: Article

References (31)

1. 1. Usmani BA: Genomic instability and metastatic progression. Pathobiology 61: 109-116, 1993
2. 2. Furlong JW: DNA analysis of breast, lung, central nervous system, endocrine, and head and neck tumors. In: Keran DF, Henson CA, Hurtubise PE (eds) Flow Cytometry and Clinical Diagnosis, American Society of Clinical Pathology Press, Chicago, 1994, pp 541-595
3. 3. Dressler LG, Scamer LC, Owens MA, Clark GN, McGuire WL: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer Res 47: 5294-5302, 1987
4. 4. Ishikawa F: Telomere crisis, the driving force in cancer cell evolution. Biochem Biophys Res Com 230: 1-6, 1997
5. n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988
6. 6. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992
7. 7. Allsopp RC, Chang E, Kashefiaazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB: Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220: 194-200, 1995
8. 8. Harley CB, Futcher AB, Greider CW: Telomeres shorten during aging of human fibroblasts. Nature 345: 458-460, 1990
9. 9. Counter CM, Avillon AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992
10. 10. Hastie ND, Dempster M, Dunlop MG, Thompson EM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with aging. Nature 346: 866-868, 1990
11. 11. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoictic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91: 9857-9860, 1994
12. 12. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, Varmus HE: Structure and variability of human chromosome ends. Mol Cell Biol 10: 518-527, 1990
13. 13. Schmitt H, Blin N, Zankl H, Scherthan H: Telomere length variation in normal and malignant human tissues. Genes Chrom Cancer 11: 171-177, 1994
14. 14. Parkinson EK: Do telomerase antagonists represent a novel anti-cancer strategy? Br J Cancer 73: 1-4, 1996
15. 15. McClintock B: The stability of broken ends of chromosomes in Zea mays. Genetics 26: 234-282, 1941
16. 16. McClintock B: The fusion of broken ends of chromosomes following nuclear fusion. Proc Natl Acad Sci USA 28: 458-463, 1942
17. 17. Takauchi K, Tashiro S, Ohtaki M, Kamada N: Telomere reduction of specific chromosome translocation in acute myelocytic leukemia. Jap J Cancer Res 85: 127-130, 1994
18. 18. Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, Murakami I, Isobe T, Inamizu T, Yumakido M: Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10: 937-944, 1995
19. 19. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y: Length of telomere repeats in neuroblastoma: correlation with prognosis and biological characteristics. Jpn J Cancer Res 83: 159-164, 1992
20. 20. Odagiri E, Kanda N, Jibiki K, Demura R, Aikawa E, Demura H: Reduction of telomeric length and c-erb2 gene amplification in human breast cancer, fibroadenoma and gynecomastia. Cancer 73: 2978-2984, 1993
21. 21. Ohyashiki J, Ohyashiki K, Fujimura K, Kawakubo K, Shimamoto T, Iwabuchi A, Toyama K: Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 54: 3557-3560, 1994
22. 22. Smith J, Yeh G: Telomere reduction in endometrial carcinoma. Am J Obstet Gynecol 167: 1883-1887, 1992
23. 23. Dahse R, Fiedler W, Ernst G: Telomeres and telomerase: Biological and clinical importance. Clin Chem 43: 708-714, 1997
24. 24. Bryant J, Hutchings K, Moyzis R, Griffith JK: A sensitive measure of telomere DNA content in human tissues. Biotechniques 23: 476-484, 1997
25. 25. Dressler LG, Seamer LC: Controls, standards and histogram interpretation in DNA flow cytometry. Meth Cell Biol 41: 241-262, 1994
26. 26. Ohyashiki K, Ohyashiki JH, Fujimura T, Kawakubo K, Shimamoto T, Saito M, Nakazawa S, Toyama K: Telomere shortening in leukemic cells is related to their genetic alterations hut not replicative capability. Cancer Genet Cytogen 78: 64-67, 1994
27. 27. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar A, Hiyama K, Mieczyslaw A, Piatyszck A, Shay J: Telomerase activity in human breast cancer. J Natl Cancer Inst 88: 116-122, 1996
28. 28. Rogalla P, Rohen C, Bonk U, Bullerdieck J: Telomere repeat fragment lengths are not correlated with histological grade in 85 breast cancers. Cancer Letters 106: 155-161, 1996
29. 29. Zhuang Z, Bertheau P, Emmert-Buck M, Liotta L, Gnarra J, Linehan M, Lubensky I: A microdissection technique for archival DNA analysis of specific cell populations in lesions 1 mm in size. Am J Path 146: 620-625, 1995
30. 30. Zhuang Z, Merino M, Chuaqui R, Liotta L, Emmert-Buck M: Identical allelic loss on chromosome 11q13 in microdissected in situ invasive human breast cancer. Cancer Res 55: 467-471, 1995
31. 31. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: 1. The value of histological grade in breast cancer; experience from a large study with long term follow-up. Histopath 19: 403-410, 1991